Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by consultant99on Jan 17, 2023 11:50am
320 Views
Post# 35228129

Warrants Still on Sale

Warrants Still on SaleI am amazed that the traceable warrants a have not kept pace with this latest share price spike. I bought a chunk yesterdaya0.155 and 0.165 but still offered at 0.175

Typically they trend at a ratio less than 2:1 warrants to shares to a low of 1.6:1 (last year when the share price hit 0.48 and the warrants 0.30) Currently that ratio is 2.31:1 (0.405 to 0.175) 

I would expect the warrant price to start picking up with higher volume as more investors discover this bargain.

Nice to see the first gap filled today. The second gap fill is in sight along with a test of 0.48; last years market high. I checked and the last long term bullish signal for TLT was in August 2022. The projected range was 0.68 to 0.75 and the time frame was by mid-April 2023. That fits nicely with Foger coming back on board and the possible announcement of BTD.
<< Previous
Bullboard Posts
Next >>